April 24 - StarMine analysis show European drug stocks like GlaxoSmithKline and Novartis have strong cash flow and increasing operating efficiency, suggesting a growing war chest for acquisitions.
European drug companies like Glaxo know bonds has had seen their cash levels snatching. Both their cash -- payments boasts high school is about eight C operations also becoming more efficiency blacks as scoring nineteen and about a seventy full. While standing script and then next year is expected to rise. This means as we could see a wave of drug Anthony coming soon says Moody's investors -- this. But are we going to be more bolt on acquisitions they'd rather than make a drug deals.